Startseite Produkte Medizinische Testmaterialien

HIV Rapid Test with 15-minute HIV-1/HIV-2/HIV-O Rapid Test with High sensitivity and specificity

Name: HIV Rapid Test with 15-minute HIV-1/HIV-2/HIV-O Rapid Test with High sensitivity and specificity
Brand: Sichuan Hundred Medcal Technology Co., Ltd.
SKU: /
Availability: InStock

Alle Produkte

Hausmedizinisches Gerät
(44)

Medizinische Schutzzubehör
(13)

Medizinisches Zahngerät
(23)

Verbrauchsmaterialien für die Chirurgie
(35)

Medizinischer Analyzer
(12)

Medizinische Testmaterialien
(21)

medizinische Diagnosegeräte
(41)

Notfallrettungsgeräte
(13)

Atemtherapiegerät
(5)

medizinische Überwachungsgeräte
(10)

Medizinische Gesundheitsprodukte
(25)

Gedrehte Sorgfalt-Versorgungen
(6)

Medizinische Sterilisationsgeräte
(1)

Reha-Medizinische Geräte
(14)

Hyperbare Ausrüstung
(2)

Bescheinigung

China Sichuan Hundred Medcal Technology Co., Ltd. zertifizierungen

Ich bin online Chat Jetzt

HIV Rapid Test with 15-minute HIV-1/HIV-2/HIV-O Rapid Test with High sensitivity and specificity

Großes Bild : HIV Rapid Test with 15-minute HIV-1/HIV-2/HIV-O Rapid Test with High sensitivity and specificity

Produktdetails:

Herkunftsort:	China
Markenname:	HDRMEDICO
Zertifizierung:	CE
Modellnummer:	/

Zahlung und Versand AGB:

Min Bestellmenge:	500 Stück
Preis:	Verhandelbar
Verpackung Informationen:	Karton
Lieferzeit:	10-15 Tage
Zahlungsbedingungen:	L/C, T/T, Westenunion, Geld Gramm, Paypal/VTB
Versorgungsmaterial-Fähigkeit:	100000PC/Monat

Kontakt Plaudern Sie Jetzt

HIV Rapid Test with 15-minute HIV-1/HIV-2/HIV-O Rapid Test with High sensitivity and specificity

Beschreibung

Produktname:	HIV-1/HIV-2/HIV-O-Schnelltest	Material:	Plastik
Produktkategorie:	In vitro-Diagnose	Testdauer:	15 Minuten
Haltbarkeit:	Zwei Jahre	Funktion:	Erkennung von Infektionskrankheiten
Hervorheben:	15-minute test duration HIV Rapid Test , Multi-type detection HIV Antibody Test , High sensitivity and specificity HIV-1/HIV-2/HIV-O Test

HIV-1/HIV-2/HIV-O Rapid Test All-Group HIV Antibody Test

The HIV-1/HIV-2/HIV-O Rapid Test is an advanced diagnostic reagent utilizing rapid immunochromatographic technology for qualitative detection of Human Immunodeficiency Virus (HIV) antibodies and antigens in human blood samples including whole blood, serum, or plasma. This comprehensive test simultaneously differentiates infections caused by HIV-1, HIV-2, and HIV-O (Group O) subtypes, providing critical information for early screening and viral typing.

Core Detection Capabilities:

The reagent employs multi-antibody coating technology to simultaneously detect:

HIV-1 Antibodies/Antigens: Covers major epidemic subtypes including Group M and rare variants
HIV-2 Antibodies: Specifically detects HIV-2 infection while avoiding cross-reactivity with HIV-1
HIV-O Antibodies: Designed for Group O strains, addressing potential missed detection by traditional reagents

Application Scenarios:

Suitable for various healthcare settings including medical institutions, disease control centers, blood donation sites, and emergency screening scenarios:

Early screening and typing confirmation in high-risk populations
Blood safety testing prior to donation procedures
Epidemiological surveys and strain monitoring programs

Technical Features of HIV-1/HIV-2/HIV-O Rapid Test:

High Sensitivity and Specificity: Utilizes combined detection strategy with recombinant antigens and monoclonal antibodies for reliable detection even in low-concentration samples
Rapid Results: Readable within 15-20 minutes without specialized equipment requirements
Simplified Operation: Supports direct testing with whole blood, minimizing sample pre-processing steps
Room Temperature Stability: Reagent can be stored and transported at ambient temperature conditions

Result Interpretation:

Positive results require confirmation via Western Blot (WB) or nucleic acid tests. Typing indications provide valuable guidance for subsequent viral load testing and treatment strategy selection.

Clinical Value of HIV-1/HIV-2/HIV-O Rapid Test:

Preliminary HIV typing through a single test significantly improves detection efficiency, particularly for precise prevention and control in regions where HIV-2 and Group O strains are prevalent. Typing information aids in optimizing antiviral treatment strategies and provides essential data support for public health surveillance.

Important Note: This product is intended for screening purposes only and must not be used as a definitive diagnostic tool. All operations must strictly follow established biosafety protocols. Positive samples should be reported according to regulatory requirements and forwarded to confirmation laboratories for further testing.

Größe und Tag:

Ansprechpartner: Mr. Terry

Telefon: 15008220675

Andere Produkte